drugset / Trial / NCT00653588

Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks

NCT00653588

Phase 3 Completed AstraZeneca
Parallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the effect of 8 weeks of treatment with Rosuvastatin with 8 weeks of treatment with Atorvastatin on low density lipoprotein cholesterol level in subjects with hypercholesterolemia and coronary heart disease (CHD) or at high risk of CHD..

Timeline

Start
2003-04
Primary completion
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 80 mg
Subject Rosuvastatin Small molecule 40 mg